Skip to main content

Zusammenfassung

Infektionen in der Gefäßchirurgie sind für den betroffenen Patienten mit einem erhöhten Amputationsrisiko/ Mortalität verbunden. Für die Kostenträger und Krankenhäuser fallen zudem — möglicherweise immense — Kosten an. Die Kommission Infektionen in der Gefäßchirurgie der DGG beschäftigt sich intensiv mit diesem Themenkomplex und begleitet als unabhängige Gruppe Neuentwicklungen und Einführungen. Sie berät auch bei komplexen Problemen oder Fragestellungen. Die Entscheidung für oder gegen ein bestimmtes Vorgehen bei der Infektion einer Gefäßrekonstruktion ist meistens individuell auf den Fall zugeschnitten, basierend auch auf den persönlichen Erfahrungen und Kenntnissen des Verantwortlichen. Besonders für die Behandlung der Gefäßprotheseninfektion gibt es kaum Evidenz. Dies wird treffend mit dem Titel einer Übersicht aus 2005 beschrieben: Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus [20].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. D’Addio V et al., Femoral bypass with femoral popliteal vein. J Vasc Surg (2005), 42, 35–39

    Article  PubMed  Google Scholar 

  2. Arbeitskreis Krankenhaus-& Praxishygiene der AWMF (2004) Leitlinien zur Hygiene in Klinik und Praxis. Perioperative Antibiotikaprophylaxe. In: Hygiene in Klinik und Praxis, AWMF-Leitlinien-Register 029/022, AWMF-online. mhp-Verlag, Wiesbaden

    Google Scholar 

  3. Bandyk DF (2000) Infection in prosthetic vascular grafts. In: Rutherford RB (Hrsg), Vascular Surgery, 733–751. Saunders, Philadelphia

    Google Scholar 

  4. Bandyk DF et al., Expanded application of in-situ replacement for prosthetic graft infection. J Vasc Surg (2001), 34, 411–419

    Article  CAS  PubMed  Google Scholar 

  5. Batt M et al., In-situ reconstruction with silver-coated polyester grafts to treat aortic infection: Early and midterm results. J Vasc Surg (2003), 38, 983–989

    Article  PubMed  Google Scholar 

  6. Braithwaite BD et al., Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. B J Surg (1998), 85(10), 1378–1381

    Article  CAS  Google Scholar 

  7. Calligaro KD et al., Intra-abdominal Aortic graft infection: complete or partial graft preservation in patients at very high risk. J Vasc Surg (2003), 38, 1199–1204

    Article  PubMed  Google Scholar 

  8. Camiade C et al., Optimization of the resistance of arterial allografts to infection: Comperative study with synthetic prostheses. Ann Vasc Surg (2001), 15, 186–196

    Article  CAS  PubMed  Google Scholar 

  9. Castier Y et al., Cryopreserved arterial allograft reconstruction for peripheral graft infection. J Vasc Surg (2005), 41, 30–37

    Article  PubMed  Google Scholar 

  10. O’Connor S et al., A sytematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg (2006), 44, 38–45

    Article  PubMed  Google Scholar 

  11. Demaria RG, Giovanni UM, Teot AI, Topical negative pressure therapie. A very useful new method to treat severe infected vascular approaches in the groin. J Cardiovasc Surg (2003), 44, 757–761

    CAS  Google Scholar 

  12. Daenens K, Fourneau I, Nevelsteen A, Ten-year experience in autogenous reconstruction with the femoral vein in the treatment of aortofemoral prosthetic infection. Europ J Vasc Surg (2003), 25, 240–245

    Article  CAS  Google Scholar 

  13. Desgranges P et al. (2008) Overt vascular infection: do cryopreserved allografts represent a simple and long lasting solution? In: Becquemin JP, Alimi YS, Gerad JL (Hrsg), Controversies and Updates in vascular surgery 2008, 303–310. Edizione Minerva Medica, Torino

    Google Scholar 

  14. Dosluoglu HH et al., Preservation of infected and exposed vascular grafts using vacuum assisted closure without muscle flap coverage. J Vasc Surg (2005), 42, 989–992

    Article  PubMed  Google Scholar 

  15. McDonnell G, Russell D, Antiseptics and Disinfectants: Activity, Action, and Resistance. Clinical Microbiology Reviews (1999), 147–179

    Google Scholar 

  16. Earnshaw JJ, The current role of rifampicin-impregnated grafts: Pragmatism versus science. Eur J Vasc Endovasc Surg (2000), 20, 409–412

    Article  CAS  PubMed  Google Scholar 

  17. Edwards WH et al., Primary graft infections. J Vasc Surg (1987), 6, 235–239 entfernen

    Article  PubMed  Google Scholar 

  18. Exton RJ, Galland RB, Major groin complications following the use of synthetic grafts. Europ J Vasc Surg (2007), 34, 188–190

    Article  CAS  Google Scholar 

  19. Feng Q et al., A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res (2000), 52(4), 662–668

    Article  CAS  PubMed  Google Scholar 

  20. Feng Q, Wu J, Chen G, Cui F, Kim T, Kim J (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52(4): 662–668

    Article  CAS  PubMed  Google Scholar 

  21. FitzGerald SF, Kelly C, Humphreys H, Diagnosis and treatment of prosthetic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother (2005), 56, 996–999

    Article  CAS  PubMed  Google Scholar 

  22. Furr JR et al., Antibacterial activity of Actisorb Plus, Actisorb and silver nitrate. J Hosp Infect (1994), 27, 201–208

    Article  CAS  PubMed  Google Scholar 

  23. Goeau-Brissoniere OA et al., Comparison of the resistence to infection of rifampin bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg (2002), 35, 1260–1263. Goeau-Brissoniere OA, Fabre D, Leflon-GuiboutV, Di Centa I, Nicolas-Chanoine MH, Coggia M (2002) Comparison of the resistence to infection of rifampin bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 35: 1260–1263

    Google Scholar 

  24. Hardman S et al., An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicinsoaked vascular grafts. Ann Vasc Surg (2004), 18(3), 308–313

    Article  CAS  PubMed  Google Scholar 

  25. Hayes PD et al., In-situ replacement of infected aortic grafts with rifampicin-bonded prostheses: The Leicester experience (1992–1998). J Vasc Surg (1999), 30, 92–98.

    Article  CAS  PubMed  Google Scholar 

  26. Hernandez-Richter T et al., Rifampicin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur J Vasc Endovasc Surg (2003), 26, 550–557

    Article  CAS  PubMed  Google Scholar 

  27. Karl T, Storck M, Die transplantaterhaltende Behandlung von postoperativen Wundheilungsstörungen nach arterieller Gefäßrekonstruktion mit alloplastischem Material mittels Vacuum Assisted Closure (V.A.C.) Therapie (2007). http://w.egms.de/en/meetings/dgch2007/07dgch488.shtml

    Google Scholar 

  28. Kieffer E et al., Allograft replacement for infraarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg (2004), 39, 1009–1017 Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A (2004) Allograft replacement for infraarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg 39: 1009–1017

    Article  PubMed  Google Scholar 

  29. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut, Prävention postoperativer Infektionen im Operationsgebiet. Bundesgesundheitsbl — Gesundheitsforsch — Gesundheitsschutz (2007), 50, 377–393

    Article  Google Scholar 

  30. Koshiko S et al., Limitations in the use of rifampicin-gelatine grafts against virulent organisms. J Vasc Surg (2002), 35, 779–785

    Article  PubMed  Google Scholar 

  31. Lavigne JP et al., Prosthetic Vascular Infection Complicated or not by Aortoenteric Fistula: Comparison of Treatment with or without Cryopreserved Allograft (homograft). Eur J Vasc Endovasc Surg (2003), 25, 416–423

    Article  PubMed  Google Scholar 

  32. Leseche G et al., Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg (2001), 34, 1–7

    Article  Google Scholar 

  33. Lovering AM et al., The elution and binding characteristics of rifampicin for three commercially available proteinsealed vascular grafts. J Antimicrobial Chemotherapy (1996), 38, 599–604

    Article  CAS  Google Scholar 

  34. Mirzaie M et al., Surgical management of vascular graft infection in severly ill patients by partial resection of the infected prosthesis. Europ J Vasc Surg (2007), 33, 610–613

    Article  CAS  Google Scholar 

  35. Mussa FF et al., Prevention and treatment of aortic graft infection. Expert Rev Anti Infect Ther (2007), 5, 305–315

    Article  PubMed  Google Scholar 

  36. Nevelsteen A, Lacroix H, Suy R, Autogenous reconstruction with the lower extremity deep veins: An alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg (1995), 22, 129–134

    Article  CAS  PubMed  Google Scholar 

  37. Niedermeier H, Wack C, Die In-situ-Rekonstruktion nach bakterieller Infektion der infrarenalen Aorta. Gefässchirurgie (2003), 8, 317–321

    Article  Google Scholar 

  38. Poulakou G, Giamarelou H (2007) Infections in vascular surgery. In: Liapis CD et al., (Hrsg), European Manual of Medicine. Vascular Surgery, 597–614. Springer, Berlin, Heidelberg, New York

    Google Scholar 

  39. Ratliff DA (2007) The prevention and treatment of vascular graft infection. In: Earnshaw JJ, Murie JA (Hrsg), The evidence for vascular surgery, 229–241. Tfm Publishing Limited, Castle Hill Barns

    Google Scholar 

  40. Ricco JB, InterGard silver bifurcated graft: Features and results of a multicenter clinical study. J Vasc Surg (2006), 44, 339–346

    Article  PubMed  Google Scholar 

  41. Ryan SV, Calligaro KD, Scharff J, Management of infected prosthetic dialysis arterivenous grafts. J Vasc Surg (2004), 39, 73–78

    Article  PubMed  Google Scholar 

  42. Slawson R, Lee H, Trevors J, Bacterial interactions with silver. Biol Metals (1990), 3, 151–154

    Article  CAS  Google Scholar 

  43. Sharif MA et al., Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg (2007), 46, 442–448

    Article  PubMed  Google Scholar 

  44. Stewart AH, Eyers PS, Earnshaw JJ, Prevention of infection in peripheral arterial reconstruction: A systematic review and meta-analysis. J Vasc Surg (2007), 46, 148–155

    Article  PubMed  Google Scholar 

  45. Strathmann M, Wingender J, Use of an oxonol dye in combination with confocal laser scanning microscopy to monitor damage of Staphylococcus aureus cells during colonization of silver-coated vascular graft. Int J Antimicrob Agents (2004), 24, 234–240

    Article  CAS  PubMed  Google Scholar 

  46. Szilagyi DE et al., Infection in arterial reconstruction with synthetic grafts. Ann Surg (1972), 176, 321–333

    Article  CAS  PubMed  Google Scholar 

  47. Ueberrueck T et al., Healing characteristics of a new silver-coated, gelatine impregnated vascular prosthesis in porcine model. Zentralbl Chir (2005), 130, 71–76

    Article  CAS  PubMed  Google Scholar 

  48. Ueberrueck T et al., Vascular Graft infection: in vitro and in vivo investigations of a new vascular graft with longterm protection. J Biomed Mater Res B Appl Biomater (2005), 74, 601–607

    PubMed  Google Scholar 

  49. Verhelst R et al., Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentric study. Ann Vasc Surg (2000), 14, 602–607 Verhelst R, Lacroix V, Vraux H, Lavigne JP, Vandamme H, Limet R, Nevelsteen A, Bellens B, Vasseur MA, WozniakB, Goffin Y (2000) Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentric study. Ann Vasc Surg 14: 602–607

    Article  CAS  PubMed  Google Scholar 

  50. Vicaretti M et al., An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc Surg (1998), 6(3), 268–273 Vicaretti M, Hawthorne WJ, Ao PY, Fletcher JP (1998) An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc Surg 6(3): 268–273

    Article  CAS  PubMed  Google Scholar 

  51. Zegelman M et al., In-situ-Rekonstruktion mit alloplastischen Prothesen beim Gefäßinfekt. Evaluation von mit Silberacetat beschichteten Prothesen. Gefäßchirurgie (2006), 11, 402–407

    Article  Google Scholar 

  52. Zegelman M et al., Metallic silver-impregnated grafts to treat infected prosthetic grafts by in-situ replacement in the infected field. Vascular (2006), 14(Suppl 1), S145–S146

    Google Scholar 

  53. Zegelman M et al. (2008) The different options for silver impregnation. In: Becquemin JP, Alimi YS, Gerad JL (Hrsg), Controversies and Updates in vascular surgery 2008, 283–288. Edizione Minerva Medica, Torino

    Google Scholar 

  54. Zühlke H, Autologe Verfahren zurTherapie von Gefäßinfektionen. Gefässchirurgie (2006), 11, 408–422

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Consortia

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Deutsche Gesellschaft für Gefäßchirurgie. (2010). Gefäßinfektionen (S1). In: Leitlinien zu Diagnostik und Therapie in der Gefäßchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04710-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04710-7_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04709-1

  • Online ISBN: 978-3-642-04710-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics